Search Result "Del(5q) MDS"
Lenalidomide for Treatment of Myelodysplastic Syndromes
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3198-3203
Author(s): Rami S. Komrokji,Alan F. List
Approach to New Therapeutics: Investigation by the Use of MDS-derived Cell Lines
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3204-3214
Author(s): Takayuki Tsujioka,Akihito Matsuoka,Yumi Tohyama,Kaoru Tohyama
Role of Immunomodulatory Drugs in the Treatment of Lymphoid and Myeloid Malignancies
Ebook: Frontiers in Clinical Drug Research: Hematology
Volume: 3 Year: 2018
Author(s): Ota Fuchs
Doi: 10.2174/9781681083674118030005
Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 51-78
Author(s): Ota Fuchs
Implication of microRNAs in the Pathogenesis of MDS
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3170-3179
Author(s): Jing Fang,Melinda Varney,Daniel T. Starczynowski
Immunomodulatory Drugs (IMiDs™): A New Treatment Option for Myelodysplastic Syndromes
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 5 Year: 2006 Page: 339-342
Author(s): Vishakha Kale, Alan F. List
Update on MDS Therapy: From Famine to Feast
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 8 Issue: 4 Year: 2010 Page: 187-198
Author(s): Preeti Chaudhary, Chirag Shah
Alterations within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 1 Year: 2016 Page: 2323-2332
Author(s): Anna Mies, Ekaterina Bulycheva, Inga Mandac Rogulj, Lorenz C. Hofbauer, Uwe- Platzbecker
World Health Organization Classification of Myelodysplastic Syndromes
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3149-3162
Author(s): Magdalena Czader,Attilio Orazi
Strategies for Biology- and Molecular-Based Treatment of Myelodysplastic Syndromes
Journal: Current Drug Targets
Volume: 6 Issue: 6 Year: 2005 Page: 713-725
Author(s): E. H. Lindberg